(Q45879922)

17 December 2017

title

Models for assessing immunogenicity and efficacy of new therapeutics for the treatment of haemophilia (English)

1 reference

17 December 2017

0 references

3

1 reference

17 December 2017

Birgit Reipert

series ordinal

2

object named as

Birgit M Reipert

1 reference

17 December 2017

author name string

Jean-Marie Saint-Remy

series ordinal

1

1 reference

17 December 2017

publication date

1 July 2012

1 reference

17 December 2017

published in

Haemophilia

1 reference

17 December 2017

volume

18 Suppl 4

1 reference

17 December 2017

page(s)

43-47

1 reference

17 December 2017

Inhibitors in congenital coagulation disorders

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02828.X

Effect of B-cell depletion using anti-CD20 therapy on inhibitory antibody formation to human FVIII in hemophilia A mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02828.X

The complex interplay of NOD-like receptors and the autophagy machinery in the pathophysiology of Crohn disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02828.X

Successful immune tolerance induction by FVIII in hemophilia A patients with inhibitor may occur without deletion of FVIII-specific T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02828.X

Oxazole-modified glycopeptides that target arthritis-associated class II MHC A(q) and DR4 proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02828.X

Maintenance and break of immune tolerance against human factor VIII in a new transgenic hemophilic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02828.X

Animal models of inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02828.X

Opportunities and limitations of mouse models humanized for HLA class II antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02828.X

Selection of the T-cell repertoire: receptor-controlled checkpoints in T-cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02828.X

Clonal selection and learning in the antibody system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02828.X

Follicular B helper T cells in antibody responses and autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02828.X

Defining rules for the peptide-MHC class II interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02828.X

The wide diversity and complexity of peptides bound to class II MHC molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02828.X

Dendritic cells and the control of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02828.X

HLA-DR-presented peptide repertoires derived from human monocyte-derived dendritic cells pulsed with blood coagulation factor VIII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02828.X

Purified human factor VIII procoagulant protein: comparative hemostatic response after infusions into hemophilic and von Willebrand disease dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02828.X

The heparin-binding exosite of factor IXa is a critical regulator of plasma thrombin generation and venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02828.X

A ferric chloride induced arterial injury model used as haemostatic effect model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02828.X

Optimization, refinement and reduction of murine in vivo experiments to assess therapeutic approaches for haemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02828.X

Successful treatment of canine hemophilia by continuous expression of canine FVIIa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02828.X

Restoring hemostatic thrombin generation at the time of cutaneous wounding does not normalize healing in hemophilia B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02828.X

Physiopathology of haemophilic arthropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02828.X

Intraarticular factor IX protein or gene replacement protects against development of hemophilic synovitis in the absence of circulating factor IX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02828.X

10.1111/J.1365-2516.2012.02828.X

21 January 2018

Identifiers

DOI

1 reference

17 December 2017

release_dspmed2elzduzckkurxk2wm24e

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dspmed2elzduzckkurxk2wm24e

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

17 December 2017